PAPA, SILVIA
 Distribuzione geografica
Continente #
NA - Nord America 1.536
EU - Europa 774
AS - Asia 393
AF - Africa 26
SA - Sud America 15
Continente sconosciuto - Info sul continente non disponibili 2
Totale 2.746
Nazione #
US - Stati Uniti d'America 1.505
IT - Italia 454
SG - Singapore 237
SE - Svezia 101
IN - India 73
DE - Germania 44
CN - Cina 38
FI - Finlandia 37
CA - Canada 25
FR - Francia 24
TG - Togo 24
NL - Olanda 20
GB - Regno Unito 17
ID - Indonesia 13
UA - Ucraina 12
AR - Argentina 11
BG - Bulgaria 11
RO - Romania 11
RU - Federazione Russa 10
IR - Iran 9
PL - Polonia 9
IE - Irlanda 8
JP - Giappone 6
HK - Hong Kong 5
MX - Messico 5
CO - Colombia 4
PT - Portogallo 4
TW - Taiwan 4
PH - Filippine 3
BE - Belgio 2
CH - Svizzera 2
ES - Italia 2
EU - Europa 2
KR - Corea 2
LT - Lituania 2
TR - Turchia 2
AT - Austria 1
BZ - Belize 1
DK - Danimarca 1
EG - Egitto 1
KZ - Kazakistan 1
LU - Lussemburgo 1
LV - Lettonia 1
ZA - Sudafrica 1
Totale 2.746
Città #
Fairfield 203
Singapore 182
Rome 178
Chandler 119
Ashburn 94
Woodbridge 92
Seattle 84
Santa Clara 80
Cambridge 76
Houston 67
Wilmington 65
Princeton 46
Milan 40
Dearborn 36
San Diego 30
San Paolo di Civitate 28
Millbury 25
Lomé 24
Beijing 21
Lawrence 21
Helsinki 17
Boston 16
Plano 16
Groningen 15
New York 15
Toronto 15
Ann Arbor 14
Jakarta 13
Naples 12
Fremont 11
Sofia 11
Andover 10
Dublin 8
Federal 8
Gdansk 8
Boardman 7
Bremen 7
Norwalk 7
Lappeenranta 6
Moscow 6
Ottawa 6
Paris 6
Leawood 5
Maruggio 5
Rende 5
Bari 4
Blackburn 4
Bogotá 4
Bologna 4
Bonate Sotto 4
Carrara 4
Des Moines 4
Falkenstein 4
Formia 4
Lisbon 4
London 4
Mexico City 4
Trieste 4
Arnsberg 3
Beauharnois 3
Buenos Aires 3
Bühl 3
Cardito 3
Chennevières-sur-marne 3
Florence 3
Hanau 3
Lavis 3
Menlo Park 3
Nanjing 3
Redwood City 3
San Mateo 3
Southend 3
Tokyo 3
Zanjan 3
Ankara 2
Bergamo 2
Brussels 2
Catania 2
Cremona 2
Denver 2
Foligno 2
Fort Worth 2
Genoa 2
Hyderabad 2
Jacksonville 2
Jinan 2
L'aquila 2
Lecce 2
Mannheim 2
New Taipei 2
New Taipei City 2
Palermo 2
Pamplona 2
Pune 2
Rochester 2
Romainville 2
Saint-Fons 2
Sala Baganza 2
Shimla 2
Stockholm 2
Totale 1.912
Nome #
Right ventricular dyssynchrony and exercise capacity in idiopathic pulmonary arterial hypertension 121
Right ventricular concentric hypertrophy and clinical worsening in idiopathic pulmonary arterial hypertension 112
Echocardiography combined with cardiopulmonary exercise testing for the prediction of outcome in idiopathic pulmonary arterial hypertension 106
Letter to the editor about the paper “right ventricular dyssynchrony predicts clinical outcomes in patients with pulmonary hypertension” by murata et al 102
Prognostic relevance of right heart reverse remodeling in idiopathic pulmonary arterial hypertension 98
Ruolo prognostico a lungo termine dell'ipertensione polmonare nei pazienti con acuta decompensated heart failure : valutazione all'ingresso in ospedale e in pre-dimissione. Roberto Badagliacca, Stefano Ghio, Michele Correale, Pasquale Petrone, Giordana Ferraioli, Beatrice Pezzuto, Roberto Poscia, Laura Scelsi, Giovanna Manzi, Silvia Papa, Daniele Berardi, Ferraretti Armando, Francesco Fedele, Carmine Dario Vizza 95
The added value of cardiopulmonary exercise testing in the follow-up of pulmonary arterial hypertension 93
Right ventricular remodeling in idiopathic pulmonary arterial hypertension. adaptive versus maladaptive morphology 91
Right intraventricular dyssynchrony in idiopathic, heritable, and anorexigen-induced pulmonary arterial hypertension. Cllinical impact and reversibility 81
Right ventricular strain curve morphology and outcome in idiopathic pulmonary arterial hypertension 79
Right ventricular dyssynchrony in idiopathic pulmonary arterial hypertension: determinants and impact on pump function 78
Usefulness of adding echocardiography of the right heart to risk-assessment scores in prostanoid-treated pulmonary arterial hypertension 75
Prognostic factors in severe pulmonary hypertension patients who need parenteral prostanoid therapy. the impact of late referral. 72
Systemic sclerosis patients with and without pulmonary arterial hypertension: a nailfold capillaroscopy study 72
Relationship between baseline ET-1 plasma levels and outcome in patients with idiopathic pulmonary hypertension treated with bosentan 71
Prognostic significance of the echocardiographic estimate of pulmonary hypertension and of right ventricular dysfunction in acute decompensated heart failure. a pilot study in HFrEF patients 70
Unusual presentation for a patent ductus arteriosus 63
Badagliacca R, Papa S, Valli G, Pezzuto B, Poscia R, Murace AC, Marinelli L, Manzi G, Berardi D, Sciomer S, Palange P, Fedele F, Vizza CD. “Incremental benefit of cardiopulmonary exercise testing for the prediction of outcome in stable prevalent idiopathic pulmonary arterial Hypertension patients”. Comunicazione Abstract del 77° Congresso Nazionale della Società Italiana di Cardiologia (2016) 59
The growing role of echocardiography in pulmonary arterial hypertension risk stratification. the missing piece 58
Right ventricular assessment matters for precision medicine.. reply to "Identifying parameters associated with response to switching from a PDE5i to riociguat in RESPITE" 57
Peripheral arterial stiffness in acute pulmonary embolism and pulmonary hypertension at short-term follow-up 56
Medical management of right ventricular dysfunction in pulmonary arterial hypertension 55
The importance of right ventricular function in patients with pulmonary arterial hypertension 54
Computational simulator models and invasive hemodynamic monitoring as tools for precision medicine in pulmonary arterial hypertension 53
Clinical implications of idiopathic pulmonary arterial hypertension phenotypes defined by cluster analysis 52
Future perspective in diabetic patients with pre- and post-capillary pulmonary hypertension 49
Therapy for pulmonary arterial hypertension due to congenital heart disease and Down's syndrome. 47
Intra-aortic balloon counterpulsation timing. a new numerical model for programming and training in the clinical environment 46
Role of cardiopulmonary exercise test in the prediction of hemodynamic impairment in patients with pulmonary arterial hypertension 46
EFFICACY OF PROSTANOID THERAPY IN PULMONARY ARTERIAL HYPERTENSION PATIENTS WITH CLINICAL WORSENING ON ORAL THERAPY 43
Long-term functional limitations on cardiopulmonary exercise testing in emotion-triggered takotsubo syndrome 42
Incidence and long-term outcomes of pregnant women complicated with pulmonary arterial hypertension during different pregnancies. a prospective cohort study from china 39
CARDIOSIM©. the first italian software platform for simulation of the cardiovascular system and mechanical circulatory and ventilatory support 38
The paradox of pulmonary arterial hypertension in Italy in the COVID-19 era. is risk of disease progression around the corner 38
Exercise energy expenditure in patients with idiopathic pulmonary arterial hypertension: impact on clinical severity and survival 36
Telehealth. a winning weapon to face the COVID-19 outbreak for patients with pulmonary arterial hypertension 36
Hemodynamics and risk assessment 2 years after the initiation of upfront ambrisentan‒tadalafil in pulmonary arterial hypertension. 34
Incremental value of cardiopulmonary exercise testing in intermediate-risk pulmonary arterial hypertension 33
Chronic thromboembolic pulmonary hypertension risk score evaluation and validation (CTEPH Solution). proposal of a study protocol aimed to realize a validated risk score for early diagnosis 32
Prognostic value of deep echocardiographic phenotyping in pulmonary arterial hypertension 31
Risk reduction and right heart reverse remodeling by upfront triple combination therapy in pulmonary arterial hypertension 28
The importance of right ventricular evaluation in risk assessment and therapeutic strategies: raising the bar in pulmonary arterial hypertension 27
Defining the clinical validity of genes reported to cause pulmonary arterial hypertension 24
Impact of parenteral prostanoids in pulmonary arterial hypertension. the relevance of timing 23
Peripheral microangiopathy changes in pulmonary arterial hypertension related to systemic sclerosis- data from a multicenter observational study 21
The importance of re-evaluating the risk score in heart failure patients: An analysis from the Metabolic Exercise Cardiac Kidney Indexes (MECKI) score database 21
Relevance of comorbidities on initial combination therapy in pulmonary arterial hypertension 21
Risk reduction and hemodynamics with initial combination therapy in pulmonary arterial hypertension 21
Comparative effectiveness of oral therapies targeting the prostacyclin pathway in pulmonary arterial hypertension. a systematic review and network meta-analysis 19
Echocardiographic evaluation of right ventricular diastolic function in pulmonary hypertension 19
Pulmonary pressure recovery in idiopathic, hereditary and drug and toxin-induced pulmonary arterial hypertension. determinants and clinical impact 18
null 18
null 15
Risk reduction and right heart reverse remodeling by upfront triple combination theraphy in pulmonary arterial hypertension. 14
null 14
Multidimensional assessment and cluster analysis for idiopathic pulmonary arterial hypertension phenotyping. 14
Right ventricular strain in pulmonary hypertension looking at the small print reply 14
Impact of non-cardiac comorbidities on diastolic properties in HFREF and HFmrEF patients 14
A 0-D model to predict the relationship between resistance and compliance in pulmonary arterial hypertension 13
Ventricular and atrial pressure-volume loops. analysis of the effects induced by right centrifugal pump assistance 13
Significant nailfold capillary loss and late capillaroscopic pattern are associated with pulmonary arterial hypertension in systemic sclerosis 13
null 13
Beta-blockers in heart failure prognosis: Lessons learned by MECKI Score Group papers 13
Multidimensional assessment and cluster analysis for idiopathic pulmonary arterial hypertension phenotyping 9
Beta-blockers in heart failure prognosis. lessons learned by MECKI score group papers 7
Risk reduction and hemodynamics with initial combination theraphy in pulmonary arterial hypertension 5
When pulmonary arterial hypertension complicates connective tissue diseases: we still have not found what we are looking for 4
null 3
Totale 2.951
Categoria #
all - tutte 12.410
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 12.410


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020255 0 0 0 0 0 59 56 48 43 23 12 14
2020/2021303 17 20 6 9 7 16 5 18 68 99 25 13
2021/2022586 51 22 10 30 36 23 7 44 51 61 152 99
2022/2023559 85 112 47 53 59 63 7 32 61 5 23 12
2023/2024435 22 57 33 22 43 28 22 35 15 67 42 49
2024/2025464 27 120 83 61 91 82 0 0 0 0 0 0
Totale 2.951